Trademark Attorney / Law Firm
Alana Bergman – Trademark Portfolio
Alana Bergman specializes in Class 10 (Medical Apparatus) trademark filings before the United States Patent and Trademark Office (USPTO), with 86 of 90 total filings concentrated in this category. The practice also covers Class 5 (Pharmaceuticals) along with 4 other Nice Classification classes. Filing activity spans from 1985 to 2022. Currently, 37 trademarks are registered and 2 are pending.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Alana Bergman's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademark applications has Alana Bergman filed?
Alana Bergman has filed 90 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 37 registered, 2 pending, 26 abandoned, 25 cancelled.
What trademark classes does Alana Bergman specialize in?
Alana Bergman has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
How long has Alana Bergman been filing trademarks?
Alana Bergman's trademark filing history with the USPTO spans from 1985 to 2022, covering 37 years of trademark practice. During this period, Alana Bergman has handled 90 trademark applications.
What is Alana Bergman's trademark registration success rate?
Alana Bergman has a 42% trademark registration rate, with 37 out of 88 resolved applications resulting in successful registration. Currently, 2 applications are pending review.